此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Improving Sleep in Cancer Patients: A Feasibility Trial (ISCAP)

2019年4月9日 更新者:Sivan Rotenberg、Dartmouth-Hitchcock Medical Center

Improving Sleep in Cancer Patients: A Feasibility Trial of Implementing Cognitive Behavioral Therapy for Insomnia During Cancer Treatments

The purpose of this study is to determine if CBT-I (cognitive behavioral therapy for insomnia) is a feasible treatment for insomnia in individuals undergoing cancer treatment.

研究概览

地位

完全的

条件

干预/治疗

详细说明

This research study is a single arm feasibility trial in which all eligible participants receive five weekly sessions of CBT-I (cognitive behavioral therapy for insomnia) delivered before or during their cancer treatments. CBT-I is a non-drug behavioral treatment for insomnia and is considered the most effective treatment for insomnia. However, CBT-I is not routinely offered to cancer patients due to unknowns about its feasibility in this population. Data will be obtained at pre- and post-CBT-I and at eight-week follow-up, and will focus on acceptability, implementation, and efficacy in order to assess feasibility. The study will focus on cancer patients who are diagnosed with gastro-intestinal (GI) cancer.

研究类型

介入性

注册 (实际的)

10

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • New Hampshire
      • Lebanon、New Hampshire、美国、03766
        • Dartmouth-Hitchcock Medical Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. 18+ years of age
  2. have insomnia disorder (SOL or WASO greater than 30 minutes for more than 6 nights in two weeks + daytime impairments)
  3. are diagnosed with gastro-intestinal cancer;
  4. have life expectancy > 6 months;
  5. are fully ambulatory indicated by the provider-rated score of greater than 2 on the Eastern Cooperative Oncology Group (ECOG) performance measure;
  6. will complete cancer treatments in no less than seven weeks, allowing for two weeks of assessments and five weeks of CBT-I;
  7. are English-speaking and able to provide voluntary, written consent.

Exclusion Criteria:

  1. unmanaged sleep apnea indicated by the scores on the STOP-BANG Questionnaire suggesting high risk for sleep apnea and not receiving any sleep apnea treatment;
  2. other sleep disorders;
  3. bipolar disorder;
  4. unmanaged serious mental illnesses;
  5. suicidal ideation/intent/plan;
  6. unstabilized pharmacological treatment for insomnia;
  7. night-shift employment.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Receiving CBT-I
This is a single arm study. All participants will receive CBT-I (cognitive behavioral therapy for insomnia).
Eligible participants will receive CBT-I by a licensed clinical psychologist.
其他名称:
  • cognitive behavioral therapy for insomnia

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change of the score on the Insomnia Severity Index (ISI)
大体时间:baseline and at 19th week
The ISI assesses the severity of insomnia symptoms and subjective daytime impairments.
baseline and at 19th week

次要结果测量

结果测量
措施说明
大体时间
Change of diary-assessed sleep onset latency
大体时间:baseline and at 19th week
Sleep onset latency is the time it takes to fall asleep
baseline and at 19th week
Change of diary-assessed wake after sleep onset
大体时间:baseline and at 19th week
wake after sleep onset is the total duration of nighttime awakenings
baseline and at 19th week
Change of actigraphy-sleep onset latency
大体时间:baseline and at 19th week
Sleep onset latency is the time it takes to fall asleep
baseline and at 19th week
Change of actigraphy-assessed wake after sleep onset
大体时间:baseline and at 19th week
wake after sleep onset is the total duration of nighttime awakenings
baseline and at 19th week

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Wai S Chan, PhD、Dartmouth-Hitchcock Medical Center

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年4月13日

初级完成 (实际的)

2019年3月31日

研究完成 (实际的)

2019年3月31日

研究注册日期

首次提交

2018年5月25日

首先提交符合 QC 标准的

2018年6月7日

首次发布 (实际的)

2018年6月19日

研究记录更新

最后更新发布 (实际的)

2019年4月11日

上次提交的符合 QC 标准的更新

2019年4月9日

最后验证

2019年4月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

There is no plan to make individual participant data available to other researchers.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅